ARTICLE | Management Tracks
Versanis recruits Pruzanski as CEO, adds Maraganore, Duncan to board
Plus BMS’s new pricing SVP and updates from Forbion, Nuvalent and more
July 21, 2022 12:09 AM UTC
Versanis Bio Inc. hired Mark Pruzanski as chairman and CEO and appointed John Maraganore and Barbara Duncan to its board. Pruzanski was previously executive chair at Versanis, and CEO of Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), a company he co-founded, until 2021. He succeeds Versanis’ co-founder Lloyd Klickstein, who is staying on as president and CSO.
Maraganore was CEO at Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) for nearly 20 years until December. Duncan was CFO and then CEO of Dov Pharmaceutical Inc., and a former CFO of Intercept. ...